Abbott drug wins approval
LIBERTYVILLE TOWNSHIP -- Abbott Laboratories won U.S. approval for Simcor, a combination pill to lower harmful cholesterol and increase the beneficial type. Simcor adds Abbott's Niaspan to a generic version of Merck & Co.'s Zocor. The Food and Drug Administration cleared the medicine for marketing, the company said Friday.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.